c‐Myc, MHCI, and NK Resistance in Immunodeficiency Lymphomas a

J. Braun,D. Felsher,L. Goodglick

DOI: https://doi.org/10.1111/j.1749-6632.1992.tb24647.x

IF: 6.499

1992-05-01

Annals of the New York Academy of Sciences

Abstract:The occurrence of B-cell lymphoma is elevated 200to 1000-fold in individuals with immune compromise due to immunosuppressive therapy, various infectious, or genetic disorders. Functional deficits of NK activity are a common feature of these immunocompromised states, and NK cell-mediated processes have been shown to suppress initial establishment or metastatic spread of malignant cells.' Because most freshly isolated tumors are NK-insensitive, resistance to NK cytolysis may be a critical step in some pathways of B-cell neoplasia. To address this issue, we have recently isolated premalignant murine B cells from normal hosts by selecting normal murine lymphoid tissue for stable in vitro cellular Because they were not exposed to host selection in vivo, these B-cell lines had a premalignant phenotype (immortal cell lines, but tumorigenic only in immunodeficient hosts). These cell lines shared several phenotypic characteristics of human immunodeficiency lymphomas, including rearranged and overexpressed c-myc loci. Moreover, NK-mediated immune surveillance was a critical component in the host resistance to these cell lines. The premalignant B-cell lines were highly NK-sensitive and their tumorigenicity was enhanced in by depletion of host NK cells with anti-asialo-GM1. In rare cases, premalignant B-cell lines yielded tumors in nonpermissive hosts. The resultant B-cell sublines (malignant variants) were increased 104-fold in tumorigenicity for permissive hosts and tumorigenic in nonpermissive hosts, and this was associated with the novel acquisition of nearly complete resistance to NK cytolysis. The present findings address the mechanism of this NK re~istance.~ Initial NK-target binding involves certain adhesion molecule interactions (e.g. LFA-l/ICAM-1,2; LFA-3KD2). This step does not account for the NK resistance of the malignant variants, because they efficiently form NK target-cell conjugates, and their expression of the adhesion molecules tested thus far (LFA-1, ICAM-1) is unchanged from premalignant lines. By a functional assay (cold-target inhibition of NK cytolysis), the malignant variants were distinguished from parental lines in their inability to induce the subsequent step of NK activation (TABLE 1). The NK activation step is poorly understood mechanistically but is related to positive and negative signaling roles of several membrane proteins; in particular, MHCI expression is inversely correlated with NK sensitivity in many tumor cells lines, especially of lymphoid lineage.5 The reciprocal relationship of MHCI and NK sensitivity was confirmed in our series